Dthera Sciences (DTHR) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
9921 CARMEL MOUNTAIN ROAD, SUITE 118 SAN DIEGO, CA 92129 |
| State of Incorp. | NV |
| Fiscal Year End | December 31 |
| Industry (SIC) | 738 - Miscellaneous Business Services (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 9/30/2018 MRQ | 12/31/2017 | 6/30/2016 | 6/30/2015 | 7/31/2014 | |||
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Current Assets | |||||||
| Cash, cash equivalents, and short-term investments | 323 | 16 | 51 | 10 | |||
| Cash and cash equivalents | 323 | 16 | 51 | 10 | |||
| Prepaid expense | 95 | 5 | 5 | ||||
| Deposits current assets | 3 | ||||||
| Total current assets: | 421 | 21 | 55 | 10 | |||
| Noncurrent Assets | |||||||
| Property, plant and equipment | 77 | 22 | |||||
| Total noncurrent assets: | 77 | 22 | |||||
| TOTAL ASSETS: | 499 | 21 | 55 | 32 | |||
| LIABILITIES AND EQUITY | |||||||
| Liabilities | |||||||
| Current Liabilities | |||||||
| Accounts payable and accrued liabilities, including: | 429 | 37 | 8 | ||||
| Accounts payable | 37 | 8 | |||||
| Other undisclosed accounts payable and accrued liabilities | 429 | ||||||
| Deferred revenue and credits | ✕ | 2 | |||||
| Due to related parties | 7 | 182 | 57 | 14 | |||
| Total current liabilities: | 438 | 219 | 65 | 14 | |||
| Noncurrent Liabilities | |||||||
| Total liabilities: | 438 | 219 | 65 | 14 | |||
| Equity | |||||||
| Equity, attributable to parent, including: | 60 | (198) | (10) | 18 | |||
| Preferred stock | 0 | ||||||
| Common stock | 47 | 48 | 48 | 5 | |||
| Additional paid in capital | 4,550 | 550 | 512 | 39 | |||
| Deferred compensation equity | (5) | ||||||
| Accumulated deficit | (4,537) | (796) | (565) | ||||
| Other undisclosed equity, attributable to parent | (26) | ||||||
| Total equity: | 60 | (198) | (10) | 18 | |||
| TOTAL LIABILITIES AND EQUITY: | 499 | 21 | 55 | 32 | |||
Income Statement (P&L) ($ in thousands)
| 9/30/2018 TTM | 12/31/2017 | 6/30/2016 | 6/30/2015 | 7/31/2014 | ||
|---|---|---|---|---|---|---|
| Revenues | 117 | |||||
| Cost of revenue (Cost of Goods and Services Sold) | (11) | (86) | ||||
| Gross profit: | (11) | 31 | ||||
| Operating expenses | (2,424) | (231) | (304) | (53) | ||
| Operating loss: | (2,424) | (242) | (304) | (22) | ||
| Nonoperating income (expense) (Other Nonoperating Income (Expense)) | (135) | 0 | (75) | |||
| Interest and debt expense | (92) | (0) | ||||
| Loss from continuing operations before equity method investments, income taxes: | (2,650) | (242) | (380) | (22) | ||
| Other undisclosed income from continuing operations before income taxes | 11 | 0 | ||||
| Loss from continuing operations: | (2,650) | (231) | (379) | (22) | ||
| Loss before gain (loss) on sale of properties: | (2,650) | (231) | (379) | (22) | ||
| Net loss: | (2,650) | (231) | (379) | (22) | ||
| Other undisclosed net income attributable to parent | 92 | |||||
| Net loss available to common stockholders, diluted: | (2,559) | (231) | (379) | (22) | ||
Comprehensive Income ($ in thousands)
| 9/30/2018 TTM | 12/31/2017 | 6/30/2016 | 6/30/2015 | 7/31/2014 | ||
|---|---|---|---|---|---|---|
| Net loss: | (2,650) | (231) | (379) | (22) | ||
| Comprehensive loss, net of tax, attributable to parent: | (2,650) | (231) | (379) | (22) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.